Xbrane to regain full rights to BIIB801, a proposed biosimilar referencing CIMZIA® | Placera

Retrieved on: 2024-08-01 19:02:46

Tags for this article:

Click the tags to see associated articles and topics

Xbrane to regain full rights to BIIB801, a proposed biosimilar referencing CIMZIA® | Placera. View article details on hiswai:

Excerpt

Xbrane Biopharma (publ) ("Xbrane" or the "Company") today announced they will regain full rights to BIIB801 following a decision by Biogen Inc.to ...

Article found on: www.placera.se